Ostatní
Návod 
Precigen, Inc.
PGEN
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.2B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-590%
ROA
0%
PE
-6
PS
223
Cena 1R
1-5
⌀ Cena
2.82
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
18-03-2026
Poslední dividenda
Profil
Precigen, Inc. objevuje a vyvíjí novou generaci genových a buněčných terapií ve Spojených státech. Zajišťuje také léčebné postupy modifikující nemoci, geneticky upravená prasata pro aplikace v regenerativní medicíně a technologie reprodukce a přenosu embryí. Kromě toho společnost nabízí platformu UltraVector, která zahrnuje pokročilé technologie konstrukce DNA a výpočetní modely pro navrhování a sestavování genetických komponent do komplexních programů genové exprese; mbIL15, gen, který zlepšuje funkční vlastnosti imunitních buněk; Šípková Růženka, nevirový transposonový/transposační systém; rekombinace AttSite, která rozbíjí a znovu spojuje DNA ve specifických sekvencích; technologická platforma AdenoVerse, knihovna umělých adenovektorových sérotypů; a L. lactis je potravinářská bakterie. Navíc poskytuje RheoSwitch, indukovatelný systém genových spínačů, který zajišťuje kvantitativní dávkově úměrnou regulaci množství a načasování exprese cílových proteinů; kill switche pro selektivní eliminaci buněčných terapií in vivo; tkáňově specifické promotory; UltraCAR-T platforma pro léčbu rakoviny; AdenoVerse imunoterapie, knihovna proprietárních adenovektorů pro genové doručování; a ActoBiotics platforma, geneticky modifikované bakterie, které doručují proteiny a peptidy na mukózních místech. Společnost Precigen, Inc. spolupracuje a uzavírá licenční smlouvy se společnostmi Alaunos Therapeutics, Inc., Ares Trading S.A., Oragenics, Inc., Castle Creek Biosciences, Inc., Intrexon Energy Partners, LLC a Intrexon Energy Partners II, LLC. Společnost byla dříve známá jako Intrexon Corporation a v lednu 2020 změnila svůj název na Precigen, Inc. Společnost Precigen, Inc. byla založena v roce 1998 a sídlí v německém městě Maryland.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
143
Založení
2013-08-08
Podobné společnosti
$ 12.37
+ $ 0.02
$ 7.35
- $ 0.51
$ 19.39
+ $ 0.92
$ 12.21
- $ 0.10
$ 9.14
+ $ 0.09
$ 6.24
+ $ 0.19
$ 56.14
+ $ 0.17
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 9.7 | 9.7 | 3.9 | 6.2 | 26.9 | 103.9 | 103.2 | 90.7 | 160.6 | 231.0 | 190.9 | 173.6 | 71.9 | 23.8 | 13.9 | 8.0 | |
| Cost of Revenues | 5.6 | 6.1 | 4.3 | 6.1 | 6.3 | 58.4 | 55.5 | 61.4 | 63.3 | 62.8 | 61.6 | 63.9 | 19.3 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 4.1 | 3.6 | -0.3 | 0.1 | 20.6 | 45.5 | 47.7 | 29.3 | 97.3 | 168.2 | 129.3 | 109.7 | 52.7 | 23.8 | 13.9 | 8.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 4.6 | 2.9 | 0.9 | 1.3 | 1.2 | 1.0 | 0.7 | 1.1 | 1.2 | 16.7 | |
| Cost of Revenues | 1.9 | 1.0 | 1.6 | 1.1 | 1.2 | 1.0 | 1.0 | 1.9 | 2.6 | 1.5 | |
| Gross Profit | 2.7 | 1.9 | -0.7 | 0.2 | 0.0 | -0.1 | -0.3 | -0.8 | -1.3 | 15.2 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 48.6 | 47.2 | 50.1 | 41.6 | 101.9 | 404.6 | 143.2 | 112.1 | 147.5 | 59.0 | 48.2 | 64.2 | 70.2 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 40.4 | 48.0 | 74.1 | 91.7 | 100.8 | 137.8 | 146.1 | 142.3 | 109.1 | 63.6 | 33.6 | 24.9 | 18.3 | |
| Depreciation & Amortization | 3.2 | 3.2 | 4.5 | 6.7 | 2.5 | 1.3 | 1.1 | 4.9 | 33.1 | 31.1 | 24.6 | 17.7 | 10.4 | 7.2 | 8.0 | 4.3 | |
| Total Operating Expenses | 114.6 | 110.2 | 134.7 | 84.2 | 95.2 | 124.3 | 133.3 | 202.7 | 542.4 | 289.3 | 254.5 | 256.5 | 122.6 | 81.8 | 89.1 | 90.4 | |
| Operating Income | -110.5 | -106.6 | -135.0 | -88.9 | -74.6 | -78.8 | -85.7 | -173.4 | -505.6 | -137.9 | -125.2 | -146.9 | -70.0 | -58.0 | -75.2 | -82.4 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.0 | 12.6 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 9.1 | 10.1 | ||
| Depreciation & Amortization | 1.1 | 0.8 | 0.6 | 0.6 | 0.7 | 0.7 | 1.6 | 1.6 | 1.6 | 1.7 | ||
| Total Operating Expenses | 24.3 | 36.4 | 31.1 | 22.8 | 28.5 | 21.2 | 60.5 | 23.6 | 22.1 | 24.3 | ||
| Operating Income | -21.7 | -34.5 | -31.8 | -22.6 | -28.5 | -21.3 | -60.8 | -24.4 | -23.4 | -7.6 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 3.2 | 3.2 | 1.4 | 3.2 | 0.1 | 1.6 | 2.5 | 3.9 | 19.1 | 19.5 | 10.2 | 1.9 | 0.8 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 3.9 | 3.9 | 0.0 | 0.5 | 6.8 | 18.9 | 18.4 | 17.7 | 8.5 | 0.6 | 0.9 | 1.2 | 0.7 | 0.1 | 0.1 | 0.2 | |
| Other Expense | -140.1 | -144.0 | 7.0 | -7.4 | -5.4 | -18.2 | -18.2 | -35.3 | -101.7 | -27.5 | -78.3 | 59.2 | -15.9 | 17.3 | -6.7 | -2.7 | |
| IBT | -250.6 | -250.6 | -128.0 | -96.4 | -80.0 | -96.9 | -103.9 | -208.7 | -536.2 | -129.7 | -194.2 | -87.0 | -85.7 | -40.9 | -81.9 | -85.3 | |
| Income Tax Expense | 0.0 | 0.0 | -1.8 | -0.5 | -0.2 | -0.2 | -0.1 | -0.9 | -21.5 | -2.9 | -3.9 | 1.0 | -0.1 | -9.8 | -0.3 | 0.2 | |
| Net Income | -250.6 | -250.6 | -126.2 | -95.9 | -79.8 | -96.8 | -103.8 | -207.8 | -509.3 | -117.0 | -186.6 | -84.5 | -81.8 | -39.0 | -81.9 | -85.3 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 1.1 | 0.5 | 0.7 | 0.9 | 0.2 | 0.3 | 0.3 | 0.6 | 0.9 | 0.9 | ||
| Interest Expense | 3.0 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Other Expense | -1.8 | -111.9 | 5.1 | -31.6 | 8.7 | -2.7 | 0.4 | 0.6 | 0.8 | 1.1 | ||
| IBT | -23.5 | -146.3 | -26.6 | -54.2 | -19.8 | -24.0 | -60.5 | -23.8 | -33.4 | -7.7 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | -1.7 | 0.0 | -0.3 | -95.1 | ||
| Net Income | -23.5 | -146.3 | -26.6 | -54.2 | -19.7 | -24.0 | -58.8 | -23.7 | -33.1 | 87.4 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.39 | $-0.40 | $-0.49 | $-0.62 | $-1.24 | $-3.93 | $-0.98 | $-1.58 | $-0.76 | $-0.83 | $-0.95 | $-14.80 | $-15.05 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.39 | $-0.40 | $-0.49 | $-0.62 | $-1.24 | $-3.93 | $-0.98 | $-1.58 | $-0.76 | $-0.83 | $-0.95 | $-14.80 | $-15.05 | |
| Shares Outstanding | 313.0 | 304.7 | 267.7 | 244.5 | 200.4 | 197.8 | 167.1 | 167.1 | 129.5 | 120.0 | 118.0 | 111.1 | 99.2 | 41.0 | 5.5 | 5.7 | |
| Diluted Shares Outstanding | 313.0 | 304.7 | 267.7 | 244.5 | 200.4 | 197.8 | 167.1 | 167.1 | 129.5 | 120.0 | 118.0 | 111.1 | 99.2 | 41.0 | 5.5 | 5.7 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.13 | $0.35 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.13 | $0.35 | ||
| Shares Outstanding | 313.0 | 296.4 | 296.4 | 293.9 | 292.9 | 275.9 | 252.4 | 249.2 | 248.9 | 248.5 | ||
| Diluted Shares Outstanding | 313.0 | 296.4 | 296.4 | 293.9 | 292.9 | 275.9 | 252.4 | 249.2 | 248.9 | 248.5 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 9.3 | 29.5 | 7.6 | 4.9 | 42.9 | 51.8 | 65.8 | 102.8 | 68.1 | 62.6 | 135.8 | 27.5 | 49.5 | 10.4 | 19.6 | |
| Short Term Investments | 10.2 | 68.4 | 55.3 | 51.1 | 72.2 | 48.3 | 9.3 | 120.1 | 11.6 | 174.6 | 102.5 | 88.5 | 128.0 | 0.3 | 0.3 | |
| Total Cash & ST Investments | 19.5 | 97.9 | 62.9 | 56.0 | 115.2 | 100.1 | 75.1 | 222.8 | 79.7 | 237.2 | 238.3 | 116.0 | 177.5 | 10.7 | 19.9 | |
| Accounts Receivable | 1.0 | 1.2 | 1.6 | 13.8 | 21.5 | 20.4 | 26.2 | 28.1 | 39.8 | 42.5 | 52.3 | 29.3 | 7.4 | 0.7 | 1.3 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.3 | 13.3 | 11.4 | 16.1 | 21.4 | 20.5 | 21.1 | 26.6 | 25.8 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 3.2 | 3.3 | 4.3 | 4.8 | 6.7 | 7.2 | 6.4 | 6.1 | 7.1 | 7.4 | 6.6 | 3.8 | 2.7 | 2.2 | 1.8 | |
| Total Current Assets | 23.7 | 102.4 | 68.8 | 118.2 | 156.6 | 148.9 | 234.6 | 285.5 | 154.0 | 315.2 | 323.8 | 174.8 | 187.6 | 13.5 | 23.0 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 0.0 | 13.8 | 6.1 | 29.5 | 24.7 | 9.3 | 17.5 | 7.6 | 10.1 | 16.5 | |
| Short Term Investments | 0.0 | 46.0 | 74.2 | 68.4 | 3.9 | 10.2 | 27.3 | 55.3 | 63.7 | 71.9 | |
| Total Cash & ST Investments | 0.0 | 59.8 | 80.2 | 97.9 | 28.6 | 19.5 | 44.8 | 62.9 | 73.8 | 88.4 | |
| Accounts Receivable | 0.0 | 0.6 | 1.1 | 1.2 | 0.7 | 1.0 | 1.2 | 1.6 | 14.1 | 14.4 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 0.0 | 2.4 | 3.3 | 3.3 | 5.2 | 3.2 | 3.6 | 4.3 | 5.1 | 2.8 | |
| Total Current Assets | 0.0 | 62.8 | 84.6 | 102.4 | 34.5 | 23.7 | 49.5 | 68.8 | 93.0 | 105.6 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 19.0 | 18.8 | 14.2 | 15.4 | 45.2 | 44.3 | 86.2 | 128.9 | 112.7 | 64.7 | 42.7 | 38.0 | 16.6 | 18.7 | 18.5 | |
| Goodwill | 24.9 | 19.1 | 26.6 | 36.9 | 54.1 | 54.4 | 63.8 | 149.6 | 153.3 | 157.2 | 165.2 | 101.1 | 13.8 | 0.0 | 0.0 | |
| Intangible Assets | 5.1 | 4.5 | 40.7 | 44.5 | 54.1 | 65.4 | 68.3 | 129.3 | 232.9 | 225.6 | 247.5 | 65.9 | 42.0 | 29.5 | 32.5 | |
| Long-Term Investments | 0.0 | 0.0 | 0.3 | 0.0 | 48.6 | 0.0 | 1.5 | 20.8 | 189.9 | 182.7 | 199.1 | 195.2 | 208.4 | 88.8 | 39.1 | |
| Other Long-Term Assets | 0.4 | 0.5 | 0.5 | 1.0 | 1.2 | 1.6 | 1.4 | 2.1 | 4.1 | 3.7 | 3.7 | 1.3 | 1.1 | 1.1 | 1.7 | |
| Total Long-Term Assets | 49.4 | 42.9 | 82.3 | 97.8 | 203.2 | 165.6 | 221.1 | 430.7 | 692.8 | 633.9 | 658.2 | 401.5 | 281.9 | 138.1 | 91.9 | |
| Total Assets | 73.2 | 145.3 | 151.0 | 216.0 | 359.9 | 314.6 | 455.8 | 716.2 | 846.9 | 949.1 | 982.0 | 576.3 | 469.5 | 151.6 | 114.8 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 0.0 | 19.4 | 19.6 | 18.8 | 18.8 | 18.9 | 19.2 | 14.2 | 14.2 | 14.1 | |
| Goodwill | 0.0 | 15.2 | 19.1 | 19.1 | 24.9 | 24.9 | 26.6 | 26.6 | 36.9 | 37.0 | |
| Intangible Assets | 0.0 | 3.8 | 4.1 | 4.5 | 4.8 | 5.1 | 38.7 | 40.7 | 40.4 | 42.7 | |
| Long-Term Investments | 0.0 | 0.0 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 5.3 | 7.1 | |
| Other Long-Term Assets | 0.0 | 0.7 | 0.5 | 0.5 | 0.5 | 0.5 | 0.8 | -8.6 | 0.9 | 1.1 | |
| Total Long-Term Assets | 0.0 | 39.1 | 44.2 | 42.9 | 49.0 | 49.4 | 85.3 | 82.3 | 97.7 | 101.9 | |
| Total Assets | 0.0 | 101.9 | 128.8 | 145.3 | 83.5 | 73.2 | 134.8 | 151.0 | 190.7 | 207.5 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 4.8 | 3.5 | 1.7 | 4.1 | 5.4 | 4.6 | 5.9 | 13.4 | 8.7 | 8.5 | 5.0 | 6.3 | 1.1 | 0.6 | 3.1 | |
| Short-Term Debt | 1.3 | 1.0 | 1.2 | 44.4 | 2.0 | 3.0 | 37.8 | 1.0 | 0.7 | 1.2 | 1.5 | 3.9 | 0.0 | 0.0 | 0.1 | |
| Other Current Liabilities | 16.5 | 16.4 | 19.5 | 30.1 | 22.8 | 31.7 | 73.5 | 31.6 | 27.9 | 31.6 | 34.1 | 20.7 | 10.9 | 6.1 | 13.0 | |
| Current Liabilities | 23.0 | 21.5 | 23.0 | 78.6 | 34.6 | 42.1 | 122.9 | 61.6 | 80.2 | 94.6 | 75.9 | 47.5 | 19.8 | 16.7 | 17.6 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 6.3 | 3.9 | 3.1 | 3.5 | 4.3 | 4.8 | 4.7 | 1.7 | 2.4 | 2.5 | |
| Short-Term Debt | 1.1 | 0.9 | 0.9 | 1.0 | 1.0 | 1.3 | 1.3 | 1.2 | 2.4 | 1.4 | |
| Other Current Liabilities | 24.2 | 17.9 | 19.4 | 16.4 | 15.5 | 16.5 | 22.3 | 19.5 | 27.6 | 26.8 | |
| Current Liabilities | 32.1 | 23.2 | 24.0 | 21.5 | 21.2 | 23.0 | 28.8 | 23.0 | 32.9 | 30.8 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 5.1 | 4.5 | 5.9 | 7.0 | 192.3 | 179.3 | 210.2 | 211.2 | 7.5 | 7.6 | 7.6 | 8.7 | 1.7 | 0.0 | 0.1 | |
| Capital Leases | 5.1 | 5.5 | 7.1 | 8.2 | 11.1 | 10.4 | 28.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | |
| Def. Tax Liability | 0.1 | 0.0 | 1.8 | 2.3 | 2.5 | 2.9 | 2.8 | 7.2 | 15.6 | 17.0 | 21.8 | 13.4 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 30.0 | 106.8 | 32.5 | 89.7 | 252.5 | 247.4 | 384.1 | 337.5 | 300.3 | 379.8 | 277.2 | 167.0 | 88.1 | 473.2 | 336.1 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 97.1 | 4.2 | 4.5 | 4.5 | 4.8 | 5.1 | 5.4 | 5.9 | 12.4 | 6.5 | |
| Capital Leases | 5.3 | 5.2 | 5.4 | 5.5 | 5.7 | 6.3 | 6.7 | 5.9 | 7.4 | 8.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 1.8 | 1.8 | 2.1 | 2.2 | |
| Total Liabilities | 129.4 | 138.7 | 142.8 | 106.8 | 28.1 | 30.0 | 37.8 | 41.6 | 43.0 | 41.3 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 580.1 | 580.1 | 0.0 | 0.0 | 386.6 | 0.0 | 0.0 | |
| Retained Earnings | -2,047.0 | -2,090.7 | -1,964.5 | -1,868.6 | -1,915.6 | -1,823.4 | -1,652.9 | -1,330.5 | -847.8 | -729.3 | -542.7 | -458.2 | -376.4 | -321.6 | -221.3 | |
| Comprehensive Income | -2.9 | 0.0 | -1.9 | -3.5 | 0.2 | 4.0 | -27.5 | -28.6 | -15.6 | -36.2 | -12.8 | 0.0 | 0.1 | -13.4 | -9.0 | |
| Total Common Equity | 43.2 | 38.5 | 118.5 | 126.3 | 107.3 | 67.2 | 71.7 | 362.9 | 533.6 | 560.2 | 694.1 | 384.8 | 366.7 | -321.6 | -221.3 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -2,317.8 | -2,171.5 | -2,144.9 | -2,090.7 | -2,071.0 | -2,047.0 | -1,988.2 | -1,964.5 | -1,931.4 | -1,911.6 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.9 | -2.8 | -3.9 | -3.6 | -2.5 | |
| Total Common Equity | 41.9 | -36.8 | -14.1 | 38.5 | 55.4 | 43.2 | 97.0 | 118.5 | 147.7 | 166.2 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 6.3 | 5.5 | 7.1 | 51.4 | 194.2 | 182.3 | 247.9 | 212.3 | 8.3 | 8.8 | 9.1 | 12.6 | 1.7 | 0.1 | 0.2 | |
| Book Value | 43.2 | 38.5 | 118.5 | 126.3 | 107.3 | 67.2 | 71.7 | 378.7 | 546.5 | 569.2 | 704.9 | 409.3 | 381.3 | -321.6 | -221.3 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 41.9 | -36.8 | -14.1 | 38.5 | 55.4 | 43.2 | 97.0 | 118.5 | 147.7 | 166.2 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -135.4 | -250.6 | -126.2 | -95.9 | 28.3 | -92.2 | -170.5 | -323.9 | -514.7 | -126.8 | -190.3 | -88.0 | -85.6 | -40.9 | -81.9 | -85.3 | |
| Depreciation & Amortization | 6.5 | 3.2 | 4.5 | 6.7 | 10.8 | 13.8 | 17.5 | 24.9 | 33.1 | 31.1 | 24.6 | 17.7 | 10.4 | 7.2 | 8.0 | 4.3 | |
| Stock-Based Compensation | 9.1 | 10.9 | 9.5 | 10.4 | 10.2 | 13.9 | 18.4 | 29.4 | 47.0 | 52.7 | 53.0 | 100.4 | 22.3 | 3.0 | 1.6 | 1.0 | |
| Change Working Capital | 8.4 | 6.6 | 4.5 | 3.4 | -22.7 | -0.8 | -20.7 | 2.4 | -20.0 | -74.6 | -17.7 | 58.8 | 12.4 | -8.3 | 6.2 | -4.7 | |
| Change In Accounts Receivable | 13.8 | -3.2 | 0.4 | 12.2 | -2.2 | -6.2 | 2.2 | -0.3 | -2.7 | 0.7 | 2.6 | -12.1 | 4.3 | -0.6 | -0.1 | 0.0 | |
| Change In Accounts Payable | 2.3 | 8.8 | 1.5 | -2.4 | 0.4 | 0.4 | -1.1 | -5.3 | 4.7 | -3.4 | 3.6 | -3.3 | 1.3 | 0.0 | -1.2 | -0.4 | |
| Change In Inventories | -2.3 | -9.2 | 0.0 | 0.0 | 2.3 | -1.9 | 2.5 | 4.1 | -0.5 | 0.7 | 3.8 | -0.8 | -7.3 | -4.6 | 0.1 | 0.2 | |
| Other Non-cash Items | 50.4 | 142.1 | 41.3 | 9.0 | -91.5 | 9.7 | 78.4 | 134.9 | 351.6 | 15.9 | 78.0 | -54.4 | 2.7 | 1.5 | -2.0 | 0.2 | |
| Cash from Operations | -70.0 | 0.0 | 0.0 | -66.9 | -65.0 | -55.8 | -77.0 | -135.9 | -124.2 | -104.1 | -56.0 | 35.7 | -19.9 | -53.7 | -61.5 | -81.8 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -23.5 | -146.3 | -26.6 | -54.2 | -19.7 | -24.0 | -58.8 | -23.7 | -33.1 | -19.8 | |
| Depreciation & Amortization | 1.1 | 0.8 | 0.6 | 0.6 | 0.7 | 0.7 | 1.6 | 1.6 | 1.6 | 1.7 | |
| Stock-Based Compensation | 2.2 | 4.4 | 1.6 | 2.7 | 2.9 | 2.1 | 2.0 | 2.6 | 2.3 | 2.3 | |
| Change Working Capital | -2.8 | 0.8 | 6.4 | 2.2 | 2.1 | -4.3 | 1.3 | 5.4 | 3.5 | 0.1 | |
| Change In Accounts Receivable | -3.3 | -0.5 | 0.5 | 0.1 | -0.4 | 0.0 | 0.5 | 0.4 | 12.5 | 0.4 | |
| Change In Accounts Payable | 6.5 | 1.5 | 0.8 | -0.1 | -0.8 | -0.8 | 0.5 | 2.7 | -0.7 | -0.2 | |
| Change In Inventories | -6.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.3 | |
| Other Non-cash Items | -0.4 | 111.3 | -1.0 | 32.3 | 5.9 | 2.8 | 32.5 | 0.1 | 10.3 | -1.3 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -15.8 | -17.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -8.0 | -2.0 | -8.6 | -1.5 | -4.9 | -7.2 | -7.5 | -37.9 | -41.6 | -46.7 | -31.6 | -12.7 | -6.4 | -1.5 | -7.5 | -13.0 | |
| Acquisitions | -10.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 64.2 | -10.8 | -14.9 | -23.4 | -18.8 | -137.4 | -70.5 | -4.5 | -6.0 | -28.7 | |
| Investments | -108.1 | -208.0 | -187.2 | -185.0 | 0.0 | -174.2 | -171.4 | -55.1 | -178.7 | -1.2 | -77.6 | -198.7 | -80.0 | -262.6 | -10.0 | -22.8 | |
| Sales of Investment | 178.9 | 208.5 | 175.0 | 183.4 | 68.4 | 100.2 | 133.0 | 190.0 | 66.2 | 174.8 | 102.3 | 88.0 | 132.1 | 45.0 | 0.0 | 0.1 | |
| Other Investing Activities | 10.8 | 0.0 | 0.0 | 0.1 | 162.9 | 6.8 | 9.4 | 0.7 | 17.8 | 0.7 | -2.7 | 0.0 | -1.3 | 0.0 | -0.2 | 0.3 | |
| Cash from Investing | 62.8 | 0.0 | 0.0 | -3.1 | 226.4 | -74.5 | 27.8 | 86.9 | -151.2 | 104.3 | -28.4 | -260.8 | -26.0 | -223.7 | -23.6 | -64.1 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.6 | -0.4 | -1.0 | -0.6 | -1.0 | -0.9 | -2.3 | -4.4 | -1.0 | -0.2 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -10.8 | |
| Investments | -10.4 | -145.3 | -28.5 | -10.4 | -112.4 | -23.2 | -34.5 | -17.2 | -31.3 | -25.1 | |
| Sales of Investment | 4.6 | 82.3 | 57.9 | 4.6 | 48.0 | 29.7 | 51.8 | 45.6 | 45.6 | 35.9 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.8 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 13.3 | 10.5 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -0.1 | 0.0 | 0.0 | -43.2 | -154.7 | -0.5 | -12.4 | -10.9 | -5.0 | -7.0 | -6.0 | -18.5 | -7.2 | -0.1 | -0.1 | -0.1 | |
| Debt Issued | -1.5 | 5.5 | -1.6 | -1.1 | 11.9 | 12.4 | -53.2 | 46.6 | 208.9 | 6.5 | 5.7 | 15.0 | 18.1 | 1.7 | 0.0 | 0.3 | |
| Issuance of Common Stock | 0.1 | 0.0 | 0.0 | 72.8 | 0.0 | 121.0 | 35.0 | 6.6 | 88.0 | 13.7 | 67.3 | 328.2 | 25.0 | 168.8 | 0.0 | 7.4 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.5 | -0.5 | 0.0 | -0.5 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.7 | -42.0 | 0.0 | -7.0 | -150.9 | 0.0 | 0.0 | |
| Other Financing Activities | 0.1 | 0.0 | 0.0 | 0.0 | -0.6 | 0.6 | 10.1 | 12.4 | 226.8 | 5.9 | -6.7 | 23.5 | 13.7 | 298.7 | 76.0 | 140.8 | |
| Cash from Financing | -0.1 | 0.0 | 0.0 | 29.6 | -155.3 | 121.2 | 32.7 | 8.1 | 309.8 | 4.3 | 12.1 | 333.2 | 24.0 | 316.5 | 75.9 | 148.1 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 98.2 | 93.0 | -0.3 | -0.1 | -0.2 | -0.6 | -0.4 | -0.4 | -0.3 | -0.6 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -7.3 | 0.7 | 21.7 | -40.7 | 5.3 | -8.9 | -16.2 | -41.7 | 34.6 | 5.5 | -73.2 | 108.3 | -22.0 | 39.1 | -9.2 | 2.3 | |
| Closing Cash Balance | 9.3 | 30.2 | 29.5 | 7.8 | 48.6 | 43.3 | 52.3 | 68.4 | 110.2 | 68.1 | 62.6 | 135.8 | 27.5 | 49.5 | 10.4 | 19.6 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 15.9 | 0.6 | 7.7 | -23.5 | 4.8 | 15.1 | -8.1 | 9.9 | -2.5 | -6.6 | |
| Closing Cash Balance | 30.2 | 14.3 | 13.8 | 6.1 | 29.5 | 24.7 | 9.6 | 17.7 | 7.6 | 10.3 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -77.9 | -89.8 | -76.8 | -68.5 | -70.0 | -63.0 | -84.5 | -173.8 | -165.8 | -150.8 | -87.6 | 22.9 | -26.2 | -55.2 | -69.0 | -94.8 | |
| Real Free Cash Flow | -87.0 | -100.7 | -86.2 | -78.9 | -80.2 | -76.9 | -102.9 | -203.2 | -212.8 | -203.5 | -140.6 | -77.5 | -48.6 | -58.3 | -70.6 | -95.8 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -24.1 | -29.5 | -19.9 | -16.9 | -9.3 | -23.6 | -25.4 | -18.4 | -16.8 | -17.2 | |
| Real Free Cash Flow | -26.2 | -33.8 | -21.6 | -19.6 | -12.1 | -25.7 | -27.4 | -21.0 | -19.1 | -19.6 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -5.7 | -3.3 | -1.4 |
| P/S | 222.7 | 32 | 9.4 |
| P/B | -10.9 | -1.3 | 5.2 |
| P/FCF | -16.1 | -6.5 | -1.5 |
| Market cap | $1.2 | $1.2 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 17.3 % | 0 % |
| Debt to Income | -39.2 % | -37.5 % | 0 % |
| Debt to Free cash flow | -96.9 % | -2365.9 % | 0 % |
| Interest expense percentage | -3.5 % | -4.3 % | 44.7 % |
| Current ratio | 0 | 3.6 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -598.6 % | -67.5 % | 0 % |
| ROA | 0 % | -33.8 % | 0 % |
| CapEx to Revenue | 47.6 % | 29.3 % | 0 % |
| RaD to Revenue | 0 % | 236.7 % | 0 % |
| ROEM | 387,360.0 | 356092.3 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 23 % | 61.6 % | 68.7 % |
| Operating margin | -1860.2 % | -422.4 % | 35.5 % |
| Net margin | -3912.9 % | -449.1 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0.1 % | 0 % |
| Dividend payout percentage | 0 % | -10.5 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 296.4 mil | 148.5 mil |
| Employee count | 0.0 tis | 0.4 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
